跳至主要内容
临床试验/TCTR20160811002
TCTR20160811002Enrolling By Invitation4 期

Effectiveness of Etoricoxib 120 mg in Pain Relief during IUD Insertion ;A Randomized, Double-blinded, Placebo controlled, Clinical Trial ’

one0 个研究点目标入组 130 人开始时间: 2016年8月11日最近更新:
适应症

试验速览

阶段
4 期
状态
Enrolling By Invitation
发起方
one
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • - Women who desired for IUD insertion
  • - Aged of 18 to 45 years old
  • - BMI between 18.5 †30.0 kg/m2
  • - Agree to join the research

排除标准

  • Women who contraindicated for IUD used
  • - Could not be ruled out pregnancy
  • - Had some degrees of physiological or anatomical distortion of uterus
  • - Recent pelvic inflammatory disease or prone to be
  • - Had confronted unexplained bleeding from genitalia
  • - Wilson’s disease
  • - Allergy to chemical agents in IUD
  • Contraindicated to etoricoxib used
  • - Allergy to chemical agents in the drug
  • - History of asthma
  • - Allergy to aspirin or others NSAIDs
  • - Heart failure
  • - Poor controlled high blood pressure (>140/90mmHg)
  • - History of ischemic heart, arteriole-venous disease, cerebrovascular disease and who had history of surgery of all above
  • - Used to have any medication which related to liver function

研究者

发起方
one

相似试验